SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-10-000036
Filing Date
2010-11-09
Accepted
2010-11-09 16:32:09
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM10Q093010 form10q093010.htm 10-Q 673287
2 exhibit311ceo.htm EX-31.1 15598
3 exhibit312cfo.htm EX-31.2 15648
4 exhibit321ceo.htm EX-32.1 6476
5 exhibit322cfo.htm EX-32.2 6798
  Complete submission text file 0001008848-10-000036.txt   2216359

Data Files

Seq Description Document Type Size
6 acor-20100930.xml EX-101.INS 207023
7 acor-20100930.xsd EX-101.SCH 10161
8 acor-20100930_cal.xml EX-101.CAL 43276
9 acor-20100930_lab.xml EX-101.LAB 141119
10 acor-20100930_pre.xml EX-101.PRE 83670
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 101176684
SIC: 2836 Biological Products, (No Diagnostic Substances)